Trial of Vaccine Therapy in Recurrent Platinum Resistant Ovarian Cancer Patients
by on Tuesday, April 12th, 2011 | No Comments
Condition: Recurrent Epithelial Ovarian Cancer
Intervention: Biological: DC-006 vaccine
Sponsor: Oslo University Hospital
Not yet recruiting – verified March 2011
Excerpt from: Trial of Vaccine Therapy in Recurrent Platinum Resistant Ovarian Cancer Patients